UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of the earliest event reported): July ~~June 8~~5, 2011

HEMACARE CORPORATION

(Exact name of registrant as specified in its charter)

California	000-15223	95-3280412
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification No.)

15350 Sherman Way, Suite 350, Van Nuys, CA 91406

(Address of principal executive offices) (Zip Code)

(818) 226-1968

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 41.01 ~~Changes~~Entry ininto ~~Registrant’s~~a ~~Certifying~~Material ~~Accountant~~Definitive Agreement

~~Effective~~On ~~June~~July 85, 2011, ~~the~~HemaCare ~~Board of Directors of Hemacare~~ Corporation (the “Company”), ~~upon~~entered ~~the~~into ~~recommendation~~a ofSecond ~~the Audit~~Amendment ~~Committee~~to ofCredit Agreement (the ~~Board~~“Amendment”) ofwith ~~Directors,~~Wells ~~dismissed~~Fargo Bank ~~Marcum LLP~~ (the “~~Marcum”~~Bank’), aspursuant to which the ~~Company’s~~parties ~~independent registered~~amended ~~public~~that ~~accounting~~certain ~~firm~~Credit ~~and~~Agreement, ~~approved~~dated ~~the~~December ~~engagement~~4, of2009, ~~SingerLewak~~as previously ~~LLP~~amended to date (the “~~SingerLewak~~Credit Agreement”), as by and among the Company’s, ~~new~~the ~~independent~~Bank ~~registered~~and ~~public~~Coral ~~accounting~~Blood ~~firm~~Services, Inc. (“Coral”).

~~Marcum~~Pursuant ~~served~~to as the ~~Company’s~~ independent registered public accounting firm since October 1, 2010, when Marcum combined its practice with Stonefield Josephson, Inc., which was then serving as the Company’s independent registered public accounting firm.Amendment:

~~The~~(a) outstanding ~~audit~~borrowings, ~~report of~~including ~~Marcum~~outstanding onadvances ~~the~~and ~~financial~~letters ~~statements~~ of ~~the~~credit, ~~Company~~under asthe ofCredit ~~and~~Agreement ~~for~~shall ~~the~~not ~~fiscal~~at ~~year~~any ~~ended December~~time 31exceed $660,150.00, ~~2010~~which ~~did~~is ~~not~~the ~~contain~~amount anoutstanding ~~adverse~~under ~~opinion~~the orCredit aAgreement ~~disclaimer~~as of ~~opinion,~~the ~~and~~date ~~was~~of ~~not~~the ~~qualified~~Amendment orand ~~modified~~is asthe toamount ~~uncertainty,~~of ~~audit~~cash ~~scope~~collateral orthe ~~accounting~~Company ~~principles.~~maintains ~~Marcum~~in ~~did~~a ~~not~~segregated, ~~provide~~blocked andeposit ~~audit~~account ~~report~~with on the ~~financial~~Bank, ~~statements~~in ofwhich the ~~Company~~Bank ashas been granted a security interest of first priority to secure all present and ~~for~~future indebtedness of the ~~fiscal~~Company ~~year~~to ~~ended~~the ~~December 31, 2009.~~Bank;

~~In connection with~~ (b) the ~~audit~~Bank ofreleased ~~the~~its ~~Company’s financial statements for the fiscal year ended December 31, 2010 and through June 8, 2011, there~~security ~~were:~~interests ~~(i)~~on noall ~~disagreements~~assets ~~between~~of the Company and ~~Marcum~~Coral onother ~~any~~than ~~matters~~a ofsecurity ~~accounting~~interest ~~principles~~on orthe ~~practices,~~cash ~~financial~~collateral ~~statement disclosure,~~the orCompany ~~auditing~~maintains ~~scope~~in a ~~or procedures~~segregated, ~~which~~blocked ~~disagreements,~~deposit ifaccount ~~not~~with ~~resolved to~~ the ~~satisfaction of Marcum~~Bank, ~~would~~and ~~have~~terminated ~~caused Marcum~~certain toancillary ~~make~~agreements ~~reference~~pursuant to which the ~~subject~~Bank ~~matter~~perfected its ofsecurity ~~the~~interest ~~disagreement~~ in ~~its~~certain ~~report~~assets onof the Company’s ~~financial statements for such fiscal year,~~ and ~~(ii)~~Coral; ~~no reportable events within the meaning set forth in Item 304(a)(1)(v) of Regulation S-K.~~and

~~During the Company’s two most recent fiscal years ended December 31, 2010 and 2009 and through June 8, 2011, the Company did not consult with SingerLewak on~~ (ic) the ~~application~~Credit ofAgreement ~~accounting~~was ~~principles~~ amended to amodify ~~specified~~and ~~transaction,~~delete ~~either~~certain ~~completed~~affirmative orand ~~proposed,~~negative orcovenants ~~the type~~ of ~~audit opinion that might be rendered on~~ the Company’s ~~financial statements,~~ and SingerLewak did not provide either a written report or oral advice to the Company that SingerLewak concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; or (ii) any matter that was the subject of any disagreement, as defined in Item 304 (a)(1)(iv) of Regulation S-K and the related instructions, or a reportable event within the meaning set forth in Item 304(a)(1)(v) of Regulation S-KCoral.

~~The~~In ~~Company~~connection ~~has provided Marcum~~ with ~~a copy of~~ the ~~disclosures~~Amendment, ~~in this Form 8-K and has requested that Marcum furnish~~ the Company ~~with~~also aentered ~~letter~~into ~~addressed to~~a ~~the~~Second ~~Securities~~Modification ~~and~~to ~~Exchange~~Promissory ~~Commission~~Note, ~~stating~~dated ~~whether~~July or5, ~~not~~2011, ~~Marcum~~to ~~agrees~~modify ~~with~~ the ~~Company’s~~maximum ~~statements~~principal ~~in this Item~~amount ~~4.01.~~available ~~Marcum~~under ~~had not responded to our request as of~~ the ~~filing~~note ~~of this Form 8-K. The Company will file a copy of Marcum’s response~~ to ~~our~~be ~~request after it is received as an exhibit to an amendment to this Form 8-K~~$660,150.00.

The foregoing summary of the Amendment is qualified in its entirety by the actual agreements attached hereto as Exhibits 10.1 and 10.2 and incorporated herein by reference.

~~SIGNATURES~~Item 9.01. Financial Statements and Exhibits

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized~~(d) Exhibits.

~~Date:~~The ~~June~~following ~~14,~~exhibits ~~2011~~are ~~HEMACARE~~filed ~~CORPORATION By /s/ Lisa Bacerra Lisa Bacerra Chief Financial Officer~~herewith:

	Exhibit Number	Description

	10.1	Second Amendment to Credit Agreement, dated July 5, 2011, among Wells Fargo Bank, HemaCare Corporation and Coral Blood Services, Inc.

	10.2	Second Modification to Promissory Note, dated July 5, 2011, among HemaCare Corporation, Coral Blood Services, Inc. and Wells Fargo Bank.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 6, 2011	HEMACARE CORPORATION


	By	/s/ Lisa Bacerra
		Lisa Bacerra,
		Chief Financial Officer

EXHIBIT INDEX

Exhibit
Number	Description

10.1	Second Amendment to Credit Agreement, dated July 5, 2011, among Wells Fargo Bank, HemaCare Corporation and Coral Blood Services, Inc.
10.2	Second Modification to Promissory Note, dated July 5, 2011, among HemaCare Corporation, Coral Blood Services, Inc. and Wells Fargo Bank.

Filing Compare · HEMACARE CORP /CA/